维百奥(北京)生物科技有限公司

400-001-2615
info@vicbio.com
产品名称 ReVacc Scientific S45R27 | Pseudovirus Influenza A HPAI H5N1 virus HaNaM with Luciferase Reporter (clade 2.3.4.4b, 2022 strain)
目录号 S45R27
别名 Pseudovirus Influenza A HPAI H5N1 virus HaNaM with Luciferase Reporter (clade 2.3.4.4b, 2022 strain)
外观 见COA
分子量 N/A
CAS N/A
溶解度
存储条件 见COA
保存时间 见COA
备注1
备注2
目录号 规格 价格 库存状态  
S45R27 200 μl; 1000 μl 咨询 咨询


ReVacc Scientific S45R27 | Pseudovirus Influenza A HPAI H5N1 virus HaNaM with Luciferase Reporter (clade 2.3.4.4b, 2022 strain)


品名:Pseudovirus Influenza A HPAI H5N1 virus HaNaM with Luciferase Reporter (clade 2.3.4.4b, 2022 strain)

货号:S45R27

品牌:ReVacc Scientific

规格:200 μl; 1000 μl


产品描述

Organism:Pathogenic Avian Influenza (HPAI) A virus, H5N1, clade 2.3.4.4b, 2022 strain

This pseudotyped virus uses lentivirus packaging to carry full length HA, NA and M of Highly Pathogenic Avian Influenza (HPAI) A virus (A/Pelecanus/Peru/VFAR-140/2022(H5N1), clade 2.3.4.4b) (GenBank: OQ565628.1). HPAI influenza H5N1 virus that is highly contagious among birds but also infect humans should be handled in BSL-4 labs. While the pseudotypes can be handled using BSL-2 containment practices. Infection of cells with this pseudotyped virus carrying luciferase reporter results in high level luciferase activity. See our titration result showing that the starting 2-fold diluted pseudovirus generates signa >100,000-fold higher than uninfected control (cell alone as background in blue). We also evaluated the neutralizing activity of one published neutralizing mAb 100F4 (Nat Commun. 2015:6:8855) and two control mAbs by using this pseudotyped virus. See figure

相关产品